Hi OWL - also looking forward to PK's report of Cannatech.
No, I'm not an accountant - have been in the finance area for over 30 years with some tertiary accountancy training.
R&D can get very complicated - essentially a Tax off-set with lots of rules. Not only the type of science involved but getting to where a company is registered etc etc. Your question is a very good one though - RMIT and Notre Dame may well qualify for R7D off-sets. It could be that MXC is an overseas registered business and that may affect R&D qualifications that does not disqualify them. Be a very good question to pose to MXC itself.
Ann: September Quarterly Activity and Cashflow Report, page-53
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.025(7.58%) |
Mkt cap ! $14.76M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 30.0¢ | $1.48K | 4.929K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 823 | 3 |
View Market Depth
| Last trade - 15.11pm 30/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |